299 related articles for article (PubMed ID: 1847588)
21. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
Rodríguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
22. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
Kiso T; Ito S; Ohta T; Asano T; Nakazato Y
Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967
[TBL] [Abstract][Full Text] [Related]
23. Vasoactive intestinal peptide receptor on liver plasma membranes: solubilization and cross-linking.
Nguyen TD; Kaiser LM
Peptides; 1990; 11(6):1255-61. PubMed ID: 1965036
[TBL] [Abstract][Full Text] [Related]
24. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
Wanke IE; Rorstad OP
Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
[TBL] [Abstract][Full Text] [Related]
25. Characterization of vasoactive intestinal peptide receptors in human liver.
Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
[TBL] [Abstract][Full Text] [Related]
26. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
27. Purification of vasoactive intestinal peptide receptor from porcine liver by a newly designed one-step affinity chromatography.
Couvineau A; Voisin T; Guijarro L; Laburthe M
J Biol Chem; 1990 Aug; 265(22):13386-90. PubMed ID: 2165502
[TBL] [Abstract][Full Text] [Related]
28. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
Andersson M; Carlquist M; Maletti M; Marie JC
FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169
[TBL] [Abstract][Full Text] [Related]
30. VIP receptors from porcine liver: high yield solubilization in a GTP-insensitive form.
Voisin T; Couvineau A; Guijarro L; Laburthe M
Life Sci; 1991; 48(2):135-41. PubMed ID: 1847224
[TBL] [Abstract][Full Text] [Related]
31. VIP binding to epithelial cell membranes of rat ventral prostate: effect of guanine nucleotides.
Carmena MJ; Prieto JC
Gen Pharmacol; 1985; 16(5):495-500. PubMed ID: 2996970
[TBL] [Abstract][Full Text] [Related]
32. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man.
Gespach C; Bawab W; Chastre E; Emami S; Yanaihara N; Rosselin G
Biochem Biophys Res Commun; 1988 Mar; 151(2):939-47. PubMed ID: 2831906
[TBL] [Abstract][Full Text] [Related]
34. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J
Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330
[TBL] [Abstract][Full Text] [Related]
35. Epithelial cells purified from choroid plexus have receptors for vasoactive intestinal polypeptide.
Nilsson C; Fahrenkrug J; Lindvall-Axelsson M; Owman C
Brain Res; 1991 Mar; 542(2):241-7. PubMed ID: 1851455
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the formation of a functional complex between vasoactive intestinal peptide, its receptor, and Gs in lung membranes.
Kermode JC; DeLuca AW; Zilberman A; Valliere J; Shreeve SM
J Biol Chem; 1992 Feb; 267(5):3382-8. PubMed ID: 1310685
[TBL] [Abstract][Full Text] [Related]
37. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties.
Laburthe M; Breant B; Rouyer-Fessard C
Eur J Biochem; 1984 Feb; 139(1):181-7. PubMed ID: 6321173
[TBL] [Abstract][Full Text] [Related]
38. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
[TBL] [Abstract][Full Text] [Related]
39. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini.
Katsushima S; Adachi H; Honda T; Sato S; Kusui T; Onishi S; Aoki E; Noguchi M; Konishi J
Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442
[TBL] [Abstract][Full Text] [Related]
40. PACAP and VIP receptors in rat liver membranes.
Robberecht P; Gourlet P; Cauvin A; Buscail L; De Neef P; Arimura A; Christophe J
Am J Physiol; 1991 Jan; 260(1 Pt 1):G97-102. PubMed ID: 1846275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]